Dramatic rise in high blood pressure contributes to many U.S. deaths
the ONA take:
Deaths related to high blood pressure have sharply risen over the last 13 years, according to recent data from the CDC’s National Center for Health Statistics.
In the CDC’s report, hypertension-related deaths was found to have increased by 61.8 percent from 2000 to 2013, and the rate of incidence rose for both sexes aged 45 or older.
The researchers, who pulled their data from national cause-of-death files, counted any mention of hypertension on death certificates as a hypertension-related death.
Overall, one out of six hypertension-related deaths was due to high blood pressure as the underlying cause.
However, the report also found that the proportion of deaths where heart disease was the underlying cause of death had dropped by about 6 percent, while those with stroke as an underlying cause dropped by about 5 percent. High blood pressure was still a contributing factor to other deaths.
Deaths as a result of heart disease, stroke, cancer, and diabetes that mentioned hypertension in certificates made up 65 percent of counted deaths in 2000, and 54 percent of those in 2013.
Deaths related to high blood pressure have sharply risen over the last 13 years.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|